Maryland SB837 regulates prescription drug coverage and utilization review, particularly for drugs reviewed by the Prescription Drug Affordability.

Maryland SB837 modifies coverage and utilization review requirements for prescription drugs reviewed by the Prescription Drug Affordability Board. It prohibits managed care organizations and certain insurers from requiring prior authorizations for drugs reviewed by the Board unless specific conditions are met, such as the Board determining the drug leads to an affordability challenge. The bill also restricts these entities from limiting, restricting, or excluding coverage of drugs reviewed by the Board under certain circumstances.

Maryland SB837 regulates prescription drug coverage and utilization review, particularly for drugs reviewed by the Prescription Drug Affordability.

Maryland SB837 modifies coverage and utilization review requirements for prescription drugs reviewed by the Prescription Drug Affordability Board. It prohibits managed care organizations and certain insurers from requiring prior authorizations for drugs reviewed by the Board unless specific conditions are met, such as the Board determining the drug leads to an affordability challenge. The bill also restricts these entities from limiting, restricting, or excluding coverage of drugs reviewed by the Board under certain circumstances.